Pretreatment expression of miR-191a may predict response to the induction chemotherapy based on cytarabine in acute myeloid leukemia patients – a single-center pilotal study
Saved in:
| Main Authors: | Agnieszka Szymczyk, Sylwia Chocholska, Katarzyna Radko, Marek Hus, Monika Podhorecka |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12186893/?tool=EBI |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pretreatment expression of miR-191a may predict response to the induction chemotherapy based on cytarabine in acute myeloid leukemia patients - a single-center pilotal study.
by: Agnieszka Szymczyk, et al.
Published: (2025-01-01) -
LOW DOSE CYTARABINE PLUS SORAFENIB IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA
by: Tural Mahmudov
Published: (2025-07-01) -
Metabolic reprogramming by PRDM16 drives cytarabine resistance in acute myeloid leukemia
by: Junji Ikeda, et al.
Published: (2025-06-01) -
Low Dose Cytarabine and Cladribine for Treatment of Relapsed or Refractory Acute Myeloid Leukemia: Clinical Experience
by: SV Gritsaev, et al.
Published: (2016-01-01) -
Bilosomes and Niosomes for Enhanced Intestinal Absorption and In Vivo Efficacy of Cytarabine in Treatment of Acute Myeloid Leukemia
by: Abdelrahman R. Said, et al.
Published: (2024-11-01)